0001181431-13-044022.txt : 20130809 0001181431-13-044022.hdr.sgml : 20130809 20130809181658 ACCESSION NUMBER: 0001181431-13-044022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130808 FILED AS OF DATE: 20130809 DATE AS OF CHANGE: 20130809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGECKER PETER CENTRAL INDEX KEY: 0001282829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 131027838 MAIL ADDRESS: STREET 1: C/O INTARCIA THERAPEUTICS, INC. STREET 2: 2000 POWELL ST., SUITE 1640 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rrd388021.xml PETER J. LANGECKER X0306 4 2013-08-08 0 0000908259 OXIGENE INC OXGN 0001282829 LANGECKER PETER C/O OXIGENE, INC. 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Common Stock, $0.01 par value per share 2013-08-08 4 A 0 72993 0 A 77993 D These shares of stock were issued to Dr. Langecker as compensation for his services to the Corporation and were fully vested upon issuance. Megan N. Gates, attorney-in-fact 2013-08-09